Sensitivity and Specificity of CA ۱۵-۳ in Detection of Breast Cancer Recurrence
Publish Year: 1384
نوع سند: مقاله ژورنالی
زبان: Persian
View: 85
This Paper With 7 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JKMU-12-3_005
تاریخ نمایه سازی: 15 اسفند 1402
Abstract:
Background: The value of CA۱۵-۳(cancer antigen ۱۵-۳) marker in early detection of breast cancer recurrence has been studied in several prospective trials. But the results of these studies are different. This may be due to variable cutoff points used for analysis, different intervals between CA۱۵-۳ measurements and the differences between patients population. This study was done to examine the predictive value, sensitivity and specificity of `CA۱۵-۳ in detection of breast cancer recurrence in Iranian patients, using a commercial available ELISA assay with a cut-off value of ۳۰ u/ml. Methods: For this purpose serial blood samples and clinical data of ۱۳۳ female patients with breast cancer referring for adjuvant treatment to Radiation Oncology Department of Shiraz University of Medical Sciences from ۱۳۷۹ to ۱۳۸۲ were collected and for all cases of clinically suspected recurrence, routine methods were used for documentation. Results: Mean age of patients was ۴۵.۶ years (SD ۱۱) and mean time of follow up was ۱۷.۵ months. Recurrence was documented in ۳۹ patients who were classified into ۴ groups: patients with documented recurrence and early elevatedmarker (true positive,۳۲ patients), patients with documented recurrence but no elevated marker(false negative, ۷ patients), those without recurrence and normal marker (true negative,۷۶ patients) and those without recurrence but elevated marker (false positive,۱۸ patients). According to these data sensitivity, specificity and positive and negative predictive values of CA۱۵-۳ were ۸۲,۸۰.۸۵,۶۴ and ۹۱.۵ percent respectively. Conclusion: CA۱۵-۳ with cut-off point of ۳۰ u/ml has an adequate sensitivity and specificity for early detection of breast cancer recurrence in Iranian patients.
Keywords:
Authors
Sh. Omidvari
Assistant Professor of Radiotherapy and Oncology, Shiraz University of Medical Science and Health Services, Shiraz, Iran
D Moslemi
Radiation Oncologist, Babol University of Medical Sciences and Health Services, Babol, Iran
A Mosalaei
Assistant Professor of Radiotherapy and Oncology, Shiraz University of Medical Science and Health Services, Shiraz, Iran
M Mohamadian Panah
Assistant Professor of Radiotherapy and Oncology, Shiraz University of Medical Science and Health Services, Shiraz, Iran
N Ahmadloo
Assistant Professor of Radiotherapy and Oncology, Shiraz University of Medical Science and Health Services, Shiraz, Iran